# Observational Biliary Tract cancer studies: 24 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials that are observational for Biliary Tract cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Biliary Tract cancer studies: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/biliary-tract-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 21, 2026 | NCT07830628 | Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer | CHA University | Observational | Not yet recruiting | Biliary Tract Cancer (BTC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830628) |
| June 25, 2026 | NCT07668024 | Study of Occupational Risk Factors for Biliary and Pancreatic Cancers | Centre Hospitalier Intercommunal Creteil | Observational | Not yet recruiting | Biliary Tract Cancer, Pancreatic Cancer | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668024) |
| April 7, 2026 | NCT07515950 | A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER | Sponsor not shown (see the record) | Observational | Not yet recruiting | Biliary Tract Cancer (BTC) | 244 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07515950) |
| March 6, 2026 | NCT07454486 | TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World... | Aarhus University Hospital | Observational | Not yet recruiting | Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), Gall Bladder Cancer, Biliary Tract Cancers (BTC)... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454486) |
| January 13, 2026 | NCT07337850 | Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers | Tata Memorial Centre | Observational | Recruiting | Gall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07337850) |
| October 3, 2025 | NCT07206355 | In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle... | University of Nottingham | Observational | Recruiting | Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), Cholangiocarcinoma, Cholangiocarcinoma Cancer, Cholangio... | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206355) |
| September 9, 2025 | NCT07161869 | Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) | Erasmus Medical Center | Observational | Recruiting | Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Perihilar Cholangiocarcinoma... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07161869) |
| September 3, 2025 | NCT07151118 | ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer | CHA University | Observational | Recruiting | Biliary Tract Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07151118) |
| August 26, 2025 | NCT07142226 | Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC | CHA University | Observational | Recruiting | Biliary Tract Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07142226) |
| April 3, 2025 | NCT06909188 | The Study of Association of Helicobacter Infections in Biliary Tract Cancers | Institute of Liver and Biliary Sciences, India | Observational | Recruiting | Biliary Tract Cancer | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06909188) |
| March 25, 2025 | NCT06893380 | Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer | CHA University | Observational | Recruiting | Locally Advanced Biliary Tract Cancers, Metastatic Biliary Tract Cancers | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06893380) |
| January 27, 2025 | NCT06793709 | A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor... | Eisai Co., Ltd. | Observational | Recruiting | Biliary Tract Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06793709) |
| October 22, 2024 | NCT06653127 | Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance | Tongji Hospital | Observational | Recruiting | Biliary Tract Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06653127) |
| October 18, 2024 | NCT06648057 | Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab | CHA University | Observational | Recruiting | Biliary Tract Cancer, Cholangiocarcinoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06648057) |
| February 23, 2024 | NCT06276153 | Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer | RenJi Hospital | Observational | Not yet recruiting | Biliary Tract Diseases, Gallbladder Cancer, Gallbladder Neoplasms | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06276153) |
| January 11, 2024 | NCT06202131 | Use of Ctdna in Patients With Gastrointestinal Tract Tumors | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Pancreas Cancer, Colon Cancer, Biliary Tract Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06202131) |
| November 18, 2023 | NCT06139042 | Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Recruiting | Liver Cancer, Biliary Tract Cancer, Pancreatic Cancer | 1,608 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06139042) |
| July 12, 2023 | NCT05942807 | Observational Monocentric Study on Biliary Tract Cancer (BABEL) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Biliary Tract Cancer | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05942807) |
| June 9, 2023 | NCT05896956 | The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary... | RenJi Hospital | Observational | Not yet recruiting | Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer, Intrahepatic Cholangiocarcinoma, Biliary... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05896956) |
| August 30, 2022 | NCT05520788 | Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing | Tongji Hospital | Observational | Recruiting | Hepatocellular Carcinoma, Biliary Tract Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05520788) |
| August 26, 2022 | NCT05517811 | Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection | University of Colorado, Denver | Observational | Recruiting | Liver Cancer, Esophageal Cancer, Colorectal Cancer, Lung Adenocarcinoma, Control, Pancreas Cancer, Biliary Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05517811) |
| January 11, 2022 | NCT05184400 | Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer | Herlev and Gentofte Hospital | Observational | Recruiting | Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05184400) |
| June 23, 2021 | NCT04935853 | Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study | GERCOR - Multidisciplinary Oncology Cooperative Group | Observational | Recruiting | Biliary Tract Cancer | 1,350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04935853) |
| September 25, 2013 | NCT01950572 | Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | National Cancer Institute (NCI) | Observational | Recruiting | Thymoma, Stomach Neoplasms, Pancreatic Neoplasms, Mesothelioma, Biliary Tract Neoplasms, Mesothelin Expressing Neoplasms | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01950572) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| CHA University | 5 |
| Tongji Hospital | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| RenJi Hospital | 2 |
| Tata Memorial Centre | 1 |
| Erasmus Medical Center | 1 |
| Institute of Liver and Biliary Sciences, India | 1 |
| Herlev and Gentofte Hospital | 1 |
| Aarhus University Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University of Colorado, Denver | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| University of Nottingham | 1 |
| [Eisai Co., Ltd.](https://specstream.ai/data/clinical-trials/company/eisai-co-ltd) | 1 |
| Centre Hospitalier Intercommunal Creteil | 1 |

## By country

| Country | Trials |
| --- | --- |
| South Korea | 5 |
| China | 3 |
| India | 2 |
| Denmark | 2 |
| Italy | 2 |
| United States | 2 |
| Netherlands | 1 |
| France | 1 |
| United Kingdom | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [B2B water treatment companies in the United States](https://specstream.ai/data/businesses/b2b-water-treatment-companies/united-states)
- [Hospices in the United States](https://specstream.ai/data/businesses/hospices/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Charter schools in the United States](https://specstream.ai/data/businesses/charter-schools/united-states)
